Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710

Recent advances with liposomes as pharmaceutical carriers

Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233

Delivering nanomedicine to solid tumors

Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Collagens—structure, function, and biosynthesis

Gelse, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.002 · Cited by 2,777

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794

Molecular mechanisms of drug resistance

Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,726

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

Brown, E. B., McKee, T. D., DiTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 844

Additional file 1 of Angiotensin blockade therapy and survival in pancreatic cancer: a population study

Keith, S. W., Maio, V., Arafat, H. A., Alcusky, M. J., Karagiannis, T., Rabinowitz, C., Lavu, H., & Louis, D. Z. (2022) · Figshare · doi:10.6084/m9.figshare.19136059

Additional file 5 of Dysregulated myosin in Hermansky-Pudlak syndrome lung fibroblasts is associated with increased cell motility

Imani, J., Bodine, S. P., Lamattina, A. M., Ma, D. D., Shrestha, S., Maynard, D., Bishop, K. S., Nwokeji, A., Malicdan, M. C. V., Testa, L. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20154304

Additional file 1 of Extracellular matrix modulating enzyme functionalized biomimetic Au nanoplatform-mediated enhanced tumor penetration and synergistic antitumor therapy for pancreatic cancer

Yang, X.-Y., Zhang, J.-G., Zhou, Q., Yu, J.-N., 鲁远飞, Wang, X.-J., Zhou, J.-P., Ding, X.-F., Du, Y.-Z., & Yu, R.-S. (2024) · Figshare · doi:10.6084/m9.figshare.26552954

Additional file 1 of Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model

Li, W., Li, S., Chen, I. X., Liu, Y., Ramjiawan, R. R., Leung, C.-H., Gerweck, L. E., Fukumura, D., Loeffler, J. S., Jain, R. K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14167780

Spatial proteogenomic profiling uncovers sensitization strategies for antibody-drug conjugate in HER2-positive breast cancer

Cai, Y., Jia, S., Wang, H., Yu, K.-D., Zhang, Y.-W., Shao, Z., Sun, H.-D., & Yu, K. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102987

Nanophysical and pharmacological approaches to modulate tumor stiffness, extracellular matrix organization and immune response of solid tumors

Nicolás‐Boluda, A. (2019) · theses.fr (ABES) · doi:10.70675/48189727z97c1z43efzbecdz2649f70acac8

Destruction du microenvironnement tumoral par application de forces mécaniques exercées par des nanoparticules magnétiques

Lopez, S. (2019) · theses.fr (ABES) · doi:10.70675/8b55b975z74ffz4dafz9253z88f55b60aae1

Influence des fibroblastes associés aux cancers (CAFs) sur la résistance à l'apoptose des cancers du sein

Louault, K. (2018) · theses.fr (ABES) · doi:10.70675/0aef1137z5689z4922z8455zdbe4b757612c

Réponses cellulaires et tissulaires de la peau humaine à l'application d'un champ électrique externe de type électroporation

Gouardères, S. (2021) · theses.fr (ABES) · doi:10.70675/e5d718b1z3c5ez4c2cz975bzd8d166a5539d

Etude de l’influence du TGF-β sur les sous-populations de fibroblastes associés au cancer et leur implication pronostique dans les cancers du pancréas

Vienot, A. (2021) · theses.fr (ABES) · doi:10.70675/25d883b4z5eadz4f1bz93f0zcfa886c08e78

Targeting mitochondrial and redox metabolism to prevent relapse in pancreatic cancer

Hadi, N. A. (2022) · theses.fr (ABES) · doi:10.70675/de0db041z7be5z4ee3z8a2cz7ca2e21ede31

Unraveling the Multifaceted Landscape of the Tumor Microenvironment through Mechanistic Insights and Therapeutic Frontiers

Pandit, D., & Sharma, P. (2026) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575442733260324060815

Systèmes innovants de délivrance de médicaments basés sur des nanomicelles pour le traitement du cancer

Tuo, W. (2015) · doi:10.70675/c7f82f5ez03a0z4e2cza125z109bcc0d7b1f

The association between cardiovascular medication use and survival in patients with advanced pancreatic adenocarcinoma

Mavros, M. N., Ladak, F., Chan, K., Nguyen, L., Coburn, N. G., & Raphael, M. J. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261449094

CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinomaPreprint

Hsu, J., Song, H., Ogawa, S., Kubota, C. S., Peck, K. L., Jacobs, E., Garcia-Rivera, L., Zhu, J., Sui, Y., Jung, W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.727290

Dense stroma limits immunogenic cell death and immunotherapy efficacy in breast cancerPreprint

Tatárová, Z., Moldaner, L., Jakubík, J., Gaidhani, G., Xu, Y., & Blumberg, D. C. (2026) · Research Square · doi:10.21203/rs.3.rs-9896344/v1

Addition of Losartan to Immune Checkpoint Blockade Improves Tumor Control and Neurological Outcomes in Models of NF2-Related Schwannomatosis

Lu, S., Chen, J., Wu, L., Sun, Y., Yin, Z., Hernandez-Meadows, M., Jones, A. P., Stemmer-Rachamimov, A., Plotkin, S. R., & Xu, L. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00929-7

The overlooked role of metascientific principles in cancer research

Martín-Villuendas, M. (2026) · Synthese · doi:10.1007/s11229-026-05710-x

Myeloid-derived suppressor cells: A promising target for anticancer immunotherapy

Sharma, V., Bansal, S., & Aggarwal, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27731-3.00015-2

The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting

Gomes, B. M., & Xavier, P. L. P. (2026) · Biochemical Society Transactions · doi:10.1042/bst20260001 · Cited by 1

Drug repurposing: Losartan reverses cancer drug resistance via microenvironment reprogramming

Han, B., Xu, Y., Li, R., Huang, P.-G., Chen, Z., & Xiao, M. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102400

Renin–angiotensin system inhibitors and immunotherapy outcomes in lung cancer: a systematic review and meta-analysis with complementary transcriptomic analyses

Li, Q., Min, X., Bai, J., Liu, X., & Ye, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1925741

NIR-II conjugated polymers for tumor sonodynamic therapy

Qin, W., & Zhou, S. (2026) · Discover Nano · doi:10.1186/s11671-026-04812-2

Understanding and targeting the tumour matrisome

Pally, D., Englund, J. I., & Naba, A. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01203-5

Active micro- and nanorobots for controlled immune modulation in protected pathological niches

Wu, D., Liu, Y., & Hu, Y. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115397

Targeting extracellular matrix mechanobiology to suppress solid tumor progression

Boone, K., Kondapaneni, R. V., Libring, S., & Reinhart‐King, C. A. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218856

Cancer-associated fibroblasts in head and neck tumours: signalling networks and therapeutic implications with insights from vestibular schwannoma

Zhang, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1927031

Repurposing of drugs to overcome extracellular matrix barriers: Losartan-enhanced cisplatin nanoparticles in 3D lung cancer spheroids

Jain, J., Sawant, P., Manchekar, T., Dyawanapelly, S., Jain, R. D., & Dandekar, P. P. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108996

Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade

Gan, L., Liu, Z., Cao, L., Meng, X., Liu, X., Wang, X., & He, Y. (2026) · Experimental Hematology and Oncology · doi:10.1186/s40164-026-00837-6

Tumor under forces: Biophysical remodeling of tumor microenvironment and associated therapeutic opportunities

Luha, R., Sankar, G., Saigaonkar, S., Mathusoothanan, S., & Tijore, A. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.102634

Renin–angiotensin system inhibitor exposure and survival outcomes in gastroesophageal cancers: A meta-analysis of observational studies

Pu, D., Luo, B., Shen, J., & Shen, W. (2026) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848261501434

A bibliometric analysis of global research trends in tumor microenvironment based nanotherapy

Wu, B., Li, R., Yang, Y., Wang, M., Liu, J., Guan, L., Liu, J., Ning, C., & Xu, Y. (2026) · Discover Nano · doi:10.1186/s11671-026-04990-z

Iron-based materials for sequential tumor microenvironment reprogramming: From mechanical decompression to immune remodeling

Chen, S., Wang, H., Gan, Y., Zhao, W., Zhang, H., Chen, X., Zhang, W., Liu, X., Liu, Y., Li, Y., et al. (2026) · The Innovation Oncology · doi:10.59717/j.xinn-oncol.2026.100044

BindingDB Entry 50007974: The Other Angiotensin II Receptor: AT

BindingDB (2021) · UC San Diego · doi:10.7270/q20868ng

Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer

Xia, T., He, Q., Shi, K., Wang, Y., Yu, Q., Zhang, L., Zhang, Q., Gao, H., Ma, L., & Liu, J. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1265553 · Cited by 51

A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan

Cun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 115

Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms

Tang, Y., Liu, Y., Wang, S., Tian, Y., Li, Y., Teng, Z., & Lu, G. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-00610-1 · Cited by 31

Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity

Yu, M., Zhang, C., Tang, Z., Tang, X., & Xu, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.011 · Cited by 51

High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer

Zhang, L., Wang, Y., Yang, Y., Liu, Y., Ruan, S., Zhang, Q., Tai, X., Chen, J., Xia, T., Qiu, Y., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b01473 · Cited by 108